Development of AECOPD identification tool (DETECT study)

Trial Identifier: D5252R00002
Sponsor: AstraZeneca
NCTID:: NCT03556475
Start Date: April 2020
Primary Completion Date: January 2021
Study Completion Date: January 2021

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
China Beijing, China
China Changsha, China
China Guangzhou, China, 510515
China Shanghai, China, 200433
China Shenyang, China, 110001
China Xi'an, China, 710061
China Xinxiang, China